Background The common p53 codon 72 polymorphism has been investigated as a risk factor for cancer in different populations; however, the results have been inconsistent. This study investigated the risk of developing gastric or colorectal cancer associated with the p53 codon 72 polymorphism in a Korean population. Methods We conducted a large-scale case-control study that included 2,213 gastric cancer patients; 1,829 colorectal cancer patients; and 1,700 healthy controls. Genotyping was performed with real-time polymerase chain reaction (PCR), using a TaqMan single-nucleotide polymorphism (SNP) genotyping assay. Results The frequencies of Arg/Arg, Arg/Pro, and Pro/ Pro genotypes of the p53 codon 72 polymorphism were 43.3, 42.0, and 13.0% in the gastric cancer patients; 40.5, 45.0, and 14.0% in the colorectal cancer patients; and 43.2, 45.6, and 11.2% in the controls, respectively. The Pro/Pro genotype was associated with an increased risk of gastric [age-and sex-adjusted odds ratio (OR) = 1.25, 95% confidence interval (CI) = 1.01-1.56, P = 0.04] and colorectal cancer (OR = 1.36, 95% CI = 1.07-1.72, P = 0.01). There were no significant interactions between the p53 codon 72 polymorphism and smoking or drinking. Conclusions Our results suggest that the Pro/Pro genotype is associated with modest increases in the risks of gastric cancer and colorectal cancer in a Korean population.
Introduction
Gastric and colorectal cancers are the most common cancers in the world. Although the incidence and mortality of gastric cancer have fallen dramatically worldwide, the current mortality is 43/100,000 in Korea and the age-adjusted incidence is as high as 70/100,000 in Korean males [1, 2] . Colorectal cancer is thought to be less common among Asians compared with Caucasians; however, recent studies in Korea and Japan have shown not only high incidence rates, but also an increasing trend in the population [3] . Gastric and colorectal cancer are described by a multistep genetic model, in which mutations within several genes, including that encoding p53, accumulate during the progression from a normal epithelium to adenoma to invasive cancer [4] [5] [6] .
TP53, which encodes p53, is a tumor suppressor gene and key player in the stress responses that preserve genomic stability, responding to a variety of insults, including DNA damage, hypoxia, metabolic stress, and oncogene activation [7, 8] . Mutations in p53 occur in at least 50% of all cancers, and more than 90% of these eliminate the ability of p53 to bind its DNA targets, underscoring the importance of this protein in tumorigenesis [9] . Recently, several common polymorphisms in TP53 have been described, including a codon 72 polymorphism (rs1042522), which involves the substitution of arginine (CGC) by proline (CCC) in exon 4. The area around exon 4 in TP53 encodes amino acids that lie close to the central hydrophobic area, which determines the conformation of the protein and, consequently, DNA-specific binding [10] . Changes in its amino acid sequence can alter the ability of p53 to bind to response elements in target genes, alter recognition motifs for post-translational modifications, or alter p53 stability and interactions with other proteins [11] [12] [13] [14] . Such changes may contribute to tumor progression and a poor prognosis [15] .
The p53 codon 72 polymorphism is associated with an increased risk of a number of cancers, including gastric and colorectal cancers [16] [17] [18] [19] . In addition, several studies have linked environmental factors such as cigarette smoking, heavy alcohol consumption, micronutrient deficiency, and dietary carcinogen exposure to these cancers [19, 20] . However, the results have been inconsistent. Therefore, we designed a large-scale case-control study to evaluate the potential role of the p53 codon 72 polymorphism in gastric and colorectal cancer risk in Korea. We also assessed interactions between the p53 codon 72 polymorphism and such environmental factors as age, cigarette smoking, and alcohol consumption; additionally, we determined the risk based on TNM stage, anatomical tumor site, and histological type.
Methods

Subjects
The study population consisted of 2,213 patients with newly diagnosed gastric cancer, 1,829 patients with newly diagnosed colorectal cancer, and 1,700 population-based 
Genotyping
Genomic DNA was extracted from peripheral blood using a QIAamp DNA Blood Mini Kit (Qiagen, Valencia, CA, USA), according to the manufacturer's protocol. Genotyping was performed with real-time polymerase chain reaction (PCR), using a TaqMan (Sigma-Proligo, The Woodlands, TX, USA) single-nucleotide polymorphism (SNP) genotyping assay. PCR primers and probes were designed and synthesized by Sigma-Aldrich (Singapore). PCR primers producing a 122-bp amplicon were as follows: forward primer, 5 0 -TCCAGATGAAGCTCCCAG AATG-3 0 and reverse primer, 5 0 -GGGAAGGGACAGA AGATGACAG-3 0 . Dual-labeled probes were 5 0 -FAM-CTGCTCCCCCCGTGGCCCC-3 0 for the C allele and 5 0 -H EX-CTGCTCCCCGCGTGGCCCC-3 0 for the G allele. Real-time PCR was performed using a Rotor-Gene 3000 multiplex system (Corbett Research, Sydney, Australia) in a 10-lL reaction volume containing 200 nM PCR primer, 10-10 nM each probe, 0.5 U f-taq polymerase (Solgent, Daejeon, Korea), and 40 ng of genomic DNA.
Statistical analysis
A t-test was used to evaluate differences in continuous variables and the v 2 test was used for categorical variables p53 and gastric and colorectal cancer 243
in the demographic characteristics of the subjects. Adjusted odds ratios (ORs) and their 95% confidence intervals (CIs) were calculated using logistic regression models, adjusted for age and sex, to estimate the association between genotype and gastric cancer and colorectal cancer. Subjects with the wild-type genotype (p53 codon 72 Arg/Arg) were considered to have a baseline risk. The expected frequency of control genotypes was checked by the Hardy-Weinberg equilibrium test. Interactions of genotype with age, smoking, and alcohol consumption were estimated using a logistic regression model, which included an interaction term, as well as variables for exposure (smoking and alcohol drinking), genotypes, and potential confounders (sex and age). The subjects for whom there were missing data for smoking, drinking, TNM stage, anatomical site, and histological type were excluded in the interaction analysis related to these variables. All tests were conducted at the P = 0.05 level of significance, and were done using SPSS for Windows version 16.0 (SPSS, Chicago, IL, USA).
Results
The demographic and tumor characteristics of the subjects are summarized in Table 1 . Because one of the colorectal cancers could not be genotyped, our ultimate sample pool included 2,213 gastric cancers; 1,828 colorectal cancers; and 1,700 controls. Compared with the controls, both cancer groups were older, included fewer females, and had fewer drinkers. The proportion of smokers in the gastric cancer group was higher than that in the controls, while the proportion among the colorectal cancer cases was lower than that in the controls. Table 2 shows the genotype distributions for the p53 codon 72 polymorphism in gastric and colorectal cancer. The observed genotype frequencies among the controls were in Hardy-Weinberg equilibrium (P = 0.516). Compared with Arg/Arg, the Pro/Pro genotype was significantly associated with increased risks of gastric [odds ratio (OR) = 1.276; 95% confidence interval (CI) = 1.026-1.587] and colorectal cancer (OR = 1.343; 95% CI = 1.056-1.693).
As shown in Table 3 , the OR of the Pro/Pro genotype was higher in gastric cardia cancer (OR = 2.476; 95% CI = 1.339-4.580) than in gastric non-cardia cancer (OR = 1.249; 95% CI = 1.001-1.558). Interestingly, in contrast to previous studies, stratification analyses by the histological type of gastric cancer indicated that the Pro/Pro genotype was associated with an increased risk of only the intestinal type (OR = 1.401; 95% CI = 1.076-1.823), but not of the diffuse (OR = 1.17; 95% CI = 0.86-1.60) and mixed types (OR = 1.08; 95% CI = 0.68-1.71). We did not find any significant associations between the p53 codon 72 polymorphism and other subgroups. Age, smoking, and drinking did not modify the association between the p53 codon 72 genotypes and the risk of gastric or colorectal cancer (Table 4) . 
Discussion
In this case-control study, we investigated the association between the p53 codon 72 polymorphism and susceptibility to gastric and colorectal cancers in a Korean population. We found that the genotype distribution differed significantly between the patients with gastric and colorectal cancer and the controls. Subgroup analyses in gastric cancer showed that the OR of the Pro/Pro genotype was higher in cardia cancer than in non-cardia cancer and was higher in the intestinal type than in the diffuse and mixed types. Several case-control studies have examined the association between the p53 codon 72 polymorphism and the risk of gastric cancer. In a Chinese study of 206 gastric cancer patients and 415 healthy controls, Mu et al. [21] showed that patients carrying the Pro/Pro genotype had a borderline increased risk of developing gastric cancer. Yi et al. [17] analyzed 291 cases and 216 controls in a Korean population and found that the p53 codon 72 Pro/Pro genotype was associated with a 3.9-fold increased risk of gastric cancer. These results are consistent with our, larger, study. By contrast, two studies reported that the Arg/Arg genotype was associated with an increased risk of gastric cancer [16, 22] , while other studies found no association [20, [23] [24] [25] [26] [27] . Although the reason for these inconsistencies is unclear, they may be explained by differences in ethnicity, small numbers of patients, and substantial interindividual variation in the susceptibility to genetic events and tumor development.
We also found a possible increased risk of colorectal cancer associated with the Pro/Pro genotype. An earlier colorectal cancer study of a Chinese population reported that the p53 codon 72 Pro/Pro genotype had a significant dose-dependent effect on colorectal cancer risk (OR = 1.6; 95% CI = 1.17-2.18 vs. OR = 2.37; 95% CI = 1.61-3.47 for Arg/Pro vs. Pro/Pro) [19] . Although we did not find a dose-dependent effect, our results are in line with those of Zhu et al. [19] . Conversely, three Caucasian studies with small sample sizes (from n = 53 to n = 93) found a significant association between the Arg/Arg genotype and an increased risk of colorectal cancer [28] [29] [30] , while two larger studies, one with 442 cases and 904 controls in the United States [18] and one with 352 cases and 316 controls in Spain [31] , found no association between the p53 codon 72 polymorphism and the risk of colorectal cancer.
In the present study, subgroup analysis in gastric cancer demonstrated that the effect size of the Pro/Pro genotype was larger in cardia cancer than in non-cardia cancer and larger in the intestinal type than in the diffuse and mixed types. It has been postulated that gastric cardia cancer and gastric non-cardia cancer differ in their epidemiological characteristics, etiology, pathogenesis, and clinical behavior [2] . Like the differences in epidemiology and pathogenesis according to tumor location, histological research has suggested that the intestinal and diffuse types of gastric cancer also have distinct characteristics. The intestinal type predominates in high-risk geographic areas such as East Asia, and is related to the prevalence of Helicobacter pylori infection among the elderly, whereas the diffuse type is found more uniformly worldwide and is apparently unrelated to H. pylori prevalence [2] . The exact biological mechanism underlying these differences is unclear; thus, a well-designed study is needed to elucidate the role of p53 codon 72 polymorphism in gastric tumorigenesis. We found no interaction between the p53 codon 72 polymorphism and age, smoking, or drinking in gastric and colorectal cancer. Previously, Sul et al. [20] reported no interaction between the p53 codon 72 polymorphism and smoking or alcohol for gastric cancer. Zhu et al. [19] indicated that there was no interaction between alcohol consumption and the p53 codon 72 genotype in relation to colorectal cancer [19] . These findings are consistent with our results.
There are certain limitations to our study. First, we cannot rule out the possibility that differential misclassification bias occurred in our study, because we gathered information about smoking and drinking retrospectively from electronic medical records in both case groups, while we gathered information about these factors from crosssectional surveys in the controls. Second, we did not consider other genetic polymorphisms.
The major strength of our study is its large sample size. Studies with small sample sizes may have insufficient statistical power to detect a slight effect or may generate a fluctuating risk estimate. As our study was based on a relatively large number of cases and controls, we were able to examine the potential effect modification of risk factors for gastric and colorectal cancers and to conduct analyses separately by tumor characteristics in gastric and colorectal cancers.
In conclusion, our results suggest that the p53 codon 72 Pro/Pro genotype is associated with a modest increased risk of gastric and colorectal cancer among Koreans, and that age, smoking, and drinking do not modify the association between the p53 codon 72 polymorphism and gastric and colorectal cancers. 
